ELV Elevance Health Loading...

From DGX earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
08:30
Jul 23 ◎
Jim Davis Chairman, CEO and President, Quest Diagnostics Incorporated DGX Q2 FY26 call
Elevance's new coverage for Alzheimer's biomarkers expands reimbursed test volume for Quest, though AB4240 is not yet covered.
ELV
HIGH
08:30
Feb 10 ◎
Jim Davis Chairman, CEO and President, Quest Diagnostics Incorporated DGX Q4 FY25 call
Re-inclusion in Elevance's networks is driving volume share gains, positive for Quest's organic growth trajectory in those states.
ELV
HIGH
08:30
Oct 21 ◎
Jim Davis President and CEO, Quest Diagnostics Incorporated DGX Q3 FY25 call
Quest regained network status with a major health plan, driving volume recovery in those states.
ELV
HIGH

About ELV Analyst Coverage

Buzzberg tracks ELV (Elevance Health) across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 3 total trade ideas tracked. Latest voices: Jim Davis.